Lynn Schenk - Net Worth and Insider Trading
Lynn Schenk Net Worth
The estimated net worth of Lynn Schenk is at least $3 Million dollars as of 2024-04-26. Lynn Schenk is the Director of Sempra and owns about 22,612 shares of Sempra (SRE) stock worth over $2 Million. Lynn Schenk is also the Director of Biogen Inc and owns about 6,425 shares of Biogen Inc (BIIB) stock worth over $1 Million. Details can be seen in Lynn Schenk's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lynn Schenk has not made any transactions after 2019-04-15 and currently still holds the listed stock(s).
Transaction Summary of Lynn Schenk
Lynn Schenk Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lynn Schenk owns 2 companies in total, including Sempra (SRE) , and Biogen Inc (BIIB) .
Click here to see the complete history of Lynn Schenk’s form 4 insider trades.
Insider Ownership Summary of Lynn Schenk
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRE | Sempra | 2019-04-15 | director |
| BIIB | Biogen Inc | 2014-01-15 | director |
Lynn Schenk Latest Holdings Summary
Lynn Schenk currently owns a total of 2 stocks. Among these stocks, Lynn Schenk owns 22,612 shares of Sempra (SRE) as of April 15, 2019, with a value of $2 Million and a weighting of 55.58%. Lynn Schenk also owns 6,425 shares of Biogen Inc (BIIB) as of January 15, 2014, with a value of $1 Million and a weighting of 44.42%.
Latest Holdings of Lynn Schenk
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRE | Sempra | 2019-04-15 | 22,612 | 71.98 | 1,627,612 |
| BIIB | Biogen Inc | 2014-01-15 | 6,425 | 202.46 | 1,300,806 |
Holding Weightings of Lynn Schenk
Lynn Schenk Form 4 Trading Tracker
According to the SEC Form 4 filings, Lynn Schenk has made a total of 0 transactions in Sempra (SRE) over the past 5 years. The most-recent trade in Sempra is the sale of 10,000 shares on April 15, 2019, which brought Lynn Schenk around $644,600.
According to the SEC Form 4 filings, Lynn Schenk has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 1,000 shares on January 15, 2014, which brought Lynn Schenk around $297,480.
Insider Trading History of Lynn Schenk
- 1
Lynn Schenk Trading Performance
Lynn Schenk Ownership Network
Ownership Network List of Lynn Schenk
Ownership Network Relation of Lynn Schenk
Lynn Schenk Owned Company Details
What does Sempra do?
Who are the key executives at Sempra?
Lynn Schenk is the director of Sempra. Other key executives at Sempra include Chief HR Officer & CAO Karen L Sedgwick , Executive VP and CFO Trevor I Mihalik , and director & Chairman & CEO and President Jeffrey W Martin .
Sempra (SRE) Insider Trades Summary
Over the past 18 months, Lynn Schenk made no insider transaction in Sempra (SRE). Other recent insider transactions involving Sempra (SRE) include a net sale of 120,117 shares made by Jeffrey W Martin , a net sale of 10,403 shares made by Karen L Sedgwick , and a net sale of 57,571 shares made by Trevor I Mihalik .
In summary, during the past 3 months, insiders sold 135,740 shares of Sempra (SRE) in total and bought 0 shares, with a net sale of 135,740 shares. During the past 18 months, 249,500 shares of Sempra (SRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 249,500 shares.
Sempra (SRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sempra Insider Transactions
Lynn Schenk Mailing Address
Above is the net worth, insider trading, and ownership report for Lynn Schenk. You might contact Lynn Schenk via mailing address: 3030 Callan Rd, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
